エピソード

  • WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults
    2025/12/17

    Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss.

    Related Content:

    • World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
    続きを読む 一部表示
    34 分
  • Head and Neck Cancer
    2025/12/15

    Head and neck cancer is the seventh most common cancer worldwide and is commonly associated with tobacco and alcohol use, or human papillomavirus (HPV) infection. Author Lara Dunn, MD, of Memorial Sloan Kettering Cancer Center joins JAMA Associate Editor Margaret Wheeler, MD, to discuss the epidemiology, risk factors, diagnosis, treatment, and prognosis of head and neck cancer.

    Related Content:

    • Head and Neck Cancer
    続きを読む 一部表示
    18 分
  • How Climate Change Affects Allergic Rhinitis and Sinusitis
    2025/12/03

    Allergic rhinitis affects about 1 in 6 US adults. A recent JAMA Insights summarizes evidence regarding the associations of climate change and air pollution with allergic rhinitis and sinusitis. The discussion includes prevention and management strategies. Coauthor Neelima Tummala, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss.

    Related Content:

    • Climate Change, Allergic Rhinitis, and Sinusitis
    続きを読む 一部表示
    12 分
  • Cannabis and Cannabinoids for Therapeutic Purposes
    2025/11/26

    Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidence-based clinical guidance.

    Related Content:

    • Therapeutic Use of Cannabis and Cannabinoids
    続きを読む 一部表示
    13 分
  • Diagnosis and Treatment of Peripheral Neuropathy
    2025/11/17

    Peripheral neuropathy affects approximately 1% of adults worldwide and can be associated with significant disability. Author Michelle Mauermann, MD, of the Mayo Clinic in Minnesota joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss diagnosis and optimal management of peripheral neuropathy.

    Related Content:

    • Peripheral Neuropathy
    続きを読む 一部表示
    22 分
  • Diagnosis and Treatment of MASLD
    2025/11/10

    Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasingly prevalent condition among adults worldwide, is associated with liver-related complications, hepatocellular carcinoma, and certain extrahepatic cancers. Author Norbert Stefan, MD, from the University Hospital of Tübingen in Tübingen, Germany, discusses this and more with JAMA Deputy Editor Kristin Walter, MD, MS.

    Related Content:

    • Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults

    -----------------------------------

    JAMA Editors' Summary

    続きを読む 一部表示
    26 分
  • Moving Toward a Safer World by 2040
    2025/11/03

    The JAMA Summit on Firearm Violence convened 60 thought leaders from a wide array of disciplines to chart a roadmap that could lead to substantial reductions in firearm harms by 2040. Frederick P. Rivara, MD, MPH, of the University of Washington joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the Summit and steps that could lead to a safer world by 2040.

    Related Content:

    • Toward a Safer World by 2040
    • Reducing Firearm Violence and Harms

    -----------------------------------

    JAMA Editors' Summary

    続きを読む 一部表示
    16 分
  • Treatment of Keratinocyte Carcinoma
    2025/10/30

    Keratinocyte carcinomas, which include basal cell carcinoma and squamous cell carcinoma, are common forms of skin cancer. Approximately 5.4 million keratinocyte carcinomas are diagnosed in the US annually. Author Mackenzie R. Wehner, MD, MPhil, of the University of Texas MD Anderson Cancer Center joins JAMA Associate Editor David Simel, MD, MHS, to discuss treatment of these types of nonmelanoma skin cancer.

    Related Content:

    • Keratinocyte Carcinoma

    -----------------------------------

    JAMA Editors' Summary

    続きを読む 一部表示
    19 分